Matts Kågedal

Matts Kågedal

Genentech, Inc - South San Francisco / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4428158
-
person_outline Matts Kågedal's MOST POPULAR ARTICLES
1-) Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activityM Kågedahl, PW Swaan, CT Redemann, M Tang, CS Craik, FC Szoka, ...Pharmaceutical research 14 (2), 176-180, 1997601997
2-) A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066—estimating occupancy in the absence of a reference regionM Kågedal, Z Cselényi, S Nyberg, P Raboisson, L Ståhle, P Stenkrona, ...Neuroimage 82, 160-169, 2013482013
3-) Modelling a spontaneously reported side effect by use of a Markov mixed-effects modelPH Zingmark, M Kågedal, MO KarlssonJournal of pharmacokinetics and pharmacodynamics 32, 261-281, 2005482005
4-) Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration–Approved Antibody–Drug …MZ Liao, D Lu, M Kågedal, D Miles, D Samineni, SN Liu, C LiClinical Pharmacology & Therapeutics 110 (5), 1216-1230, 2021462021
5-) Blood–brain barrier penetration of zolmitriptan—modelling of positron emission tomography dataM Bergström, R Yates, A Wall, M Kågedal, S Syvänen, B LångströmJournal of pharmacokinetics and pharmacodynamics 33, 75-91, 2006422006